Hwail Pharmaceutical Co.Ltd (061250) — Free Cash Flow Generation Index
Hwail Pharmaceutical Co.Ltd (061250) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of ₩5.44 Billion represents 1% of operating cash flow (₩6.82 Billion). Explore 061250 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hwail Pharmaceutical Co.Ltd Free Cash Flow Generation Index (2011–2024)
Historical FCF Generation Index trend for Hwail Pharmaceutical Co.Ltd across 10 annual periods. For the full cash flow conversion analysis, see Hwail Pharmaceutical Co.Ltd operating cash flow efficiency.
Annual Free Cash Flow Generation for Hwail Pharmaceutical Co.Ltd (2011–2024)
Year-by-year Free Cash Flow Generation Index for Hwail Pharmaceutical Co.Ltd. Check Hwail Pharmaceutical Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.98x | ₩-23.00 Billion | ₩11.63 Billion | ₩34.63 Billion | ▼ -382.1% |
| 2023 | 0.70x | ₩4.92 Billion | ₩7.02 Billion | ₩2.10 Billion | ▼ -20.1% |
| 2021 | 0.88x | ₩17.62 Billion | ₩20.09 Billion | ₩2.47 Billion | ▼ -32.2% |
| 2019 | 1.29x | ₩4.78 Billion | ₩3.69 Billion | ₩1.09 Billion | ▲ +6.4% |
| 2018 | 1.22x | ₩8.72 Billion | ₩7.17 Billion | ₩1.55 Billion | ▲ +14.6% |
| 2017 | 1.06x | ₩8.85 Billion | ₩8.34 Billion | ₩513.62 Million | ▲ +1.8% |
| 2016 | 1.04x | ₩9.99 Billion | ₩9.58 Billion | ₩413.00 Million | ▼ -55.0% |
| 2013 | 2.32x | ₩16.16 Billion | ₩6.97 Billion | ₩9.18 Billion | ▼ -73.3% |
| 2012 | 8.69x | ₩8.73 Billion | ₩1.00 Billion | ₩7.72 Billion | ▲ +417.8% |
| 2011 | 1.68x | ₩13.18 Billion | ₩7.86 Billion | ₩5.32 Billion | — |